Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Without Psychotic Features”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00036309
What this trial is testing

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Who this might be right for
Depressive Disorder
Eli Lilly and Company
Large-scale testing (Phase 3)Study completedNCT00035321
What this trial is testing

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 600
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Not applicableLooking for participantsNCT07459270
What this trial is testing

Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use

Who this might be right for
Methamphetamine Induced PsychosisCannabis Use
Elazığ Mental Health and Diseases Hospital 90
Post-approval studies (Phase 4)Study completedNCT01670019
What this trial is testing

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Who this might be right for
Major Depressive Disorder Without Psychotic Features
Duke University 46
Not applicableUnknownNCT02501226
What this trial is testing

Effectiveness of the First French Psychoeducational Program on Unipolar Depression

Who this might be right for
Unipolar Depressed OutpatientsMild SeverityWithout Psychotic Features
University Hospital, Montpellier 332
Not applicableStudy completedNCT02218853
What this trial is testing

Psychosis and Affective Research Domains and Intermediate Phenotypes

Who this might be right for
Bipolar I Disorder, Unspecified, With Psychotic FeaturesBipolar I Disorder, Unspecified, Without Psychotic Features
University of Texas Southwestern Medical Center 113
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524
Not applicableEnded earlyNCT01310140
What this trial is testing

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Who this might be right for
Major Depressive DisorderMajor Depressive Disorder w/ Psychotic FeaturesMetabolic Syndrome
Massachusetts General Hospital 14